HK1047932A1 - 製備2-雜環基甲基苯甲酸衍生物的方法 - Google Patents
製備2-雜環基甲基苯甲酸衍生物的方法Info
- Publication number
- HK1047932A1 HK1047932A1 HK03100101.3A HK03100101A HK1047932A1 HK 1047932 A1 HK1047932 A1 HK 1047932A1 HK 03100101 A HK03100101 A HK 03100101A HK 1047932 A1 HK1047932 A1 HK 1047932A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- producing
- benzoic acid
- acid derivatives
- methyl benzoic
- heterocyclyl methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/04—1,2,3-Triazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19929348A DE19929348A1 (de) | 1999-06-26 | 1999-06-26 | Verfahren zur Herstellung von 2-Heterocyclylmethyl-benzoesäurederivaten |
PCT/EP2000/005412 WO2001000595A1 (de) | 1999-06-26 | 2000-06-13 | Verfahren zur herstellung von 2-heterocyclylmethyl-benzoesäurederivaten |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1047932A1 true HK1047932A1 (zh) | 2003-03-14 |
Family
ID=7912666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK03100101.3A HK1047932A1 (zh) | 1999-06-26 | 2003-01-03 | 製備2-雜環基甲基苯甲酸衍生物的方法 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1194419A1 (zh) |
JP (1) | JP2003503396A (zh) |
CN (1) | CN1358176A (zh) |
AU (1) | AU5532500A (zh) |
BR (1) | BR0012451A (zh) |
DE (1) | DE19929348A1 (zh) |
HK (1) | HK1047932A1 (zh) |
IL (1) | IL146662A0 (zh) |
MX (1) | MXPA01013263A (zh) |
WO (1) | WO2001000595A1 (zh) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6914082B2 (en) | 2001-12-14 | 2005-07-05 | Conocophillips Company | Slurry bubble reactor operated in well-mixed gas flow regime |
US7230035B2 (en) | 2002-12-30 | 2007-06-12 | Conocophillips Company | Catalysts for the conversion of methane to synthesis gas |
DE102006024024A1 (de) | 2006-05-23 | 2007-11-29 | Bayer Healthcare Aktiengesellschaft | Substituierte Arylimidazolone und -triazolone sowie ihre Verwendung |
JP5486928B2 (ja) | 2007-02-26 | 2014-05-07 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 11β−ヒドロキシステロイドデヒドロゲナーゼ1のサイクリックウレアおよびカルバメートインヒビター |
JP5451611B2 (ja) | 2007-07-26 | 2014-03-26 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 11β−ヒドロキシステロイドデヒドロゲナーゼ1のサイクリックインヒビター |
WO2009075835A1 (en) | 2007-12-11 | 2009-06-18 | Vitae Pharmaceutical, Inc | CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1 |
TW200934490A (en) | 2008-01-07 | 2009-08-16 | Vitae Pharmaceuticals Inc | Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1 |
JP5490020B2 (ja) | 2008-01-24 | 2014-05-14 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状カルバゼート及びセミカルバジドインヒビター |
JP5734666B2 (ja) | 2008-02-11 | 2015-06-17 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 11β−ヒドロキシステロイドデヒドロゲナーゼ1の1,3−オキサアゼパン−2−オン及び1,3−ジアゼパン−2−オン阻害剤 |
US8598160B2 (en) | 2008-02-15 | 2013-12-03 | Vitae Pharmaceuticals, Inc. | Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
US8242111B2 (en) | 2008-05-01 | 2012-08-14 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
CL2009001058A1 (es) | 2008-05-01 | 2010-09-10 | Vitae Pharmaceuticals Inc | Compuestos derivados de oxazinas sustituidas, inhibidores de la 11b-hidroxiesteroide deshidrogenasa de tipo-1; composicion farmaceutica; y uso del compuesto para inhibir la actividad de 11b-hsd1, como en el tratamiento de la diabetes, dislipidemia, hipertension, obesidad, cancer, glaucoma, entre otras. |
PL2300461T3 (pl) | 2008-05-01 | 2013-09-30 | Vitae Pharmaceuticals Inc | Cykliczne inhibitory dehydrogenazy 11beta-hydroksysteroidów 1 |
JP5538365B2 (ja) | 2008-05-01 | 2014-07-02 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤 |
EP2687525B1 (en) | 2008-07-25 | 2015-09-23 | Boehringer Ingelheim International GmbH | Cyclic inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
CA2729998A1 (en) | 2008-07-25 | 2010-01-28 | Boehringer Ingelheim International Gmbh | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
DE102008060967A1 (de) | 2008-12-06 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Phenylsulfonyltriazolone und ihre Verwendung |
WO2010089303A1 (en) | 2009-02-04 | 2010-08-12 | Boehringer Ingelheim International Gmbh | CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1 |
DE102010001064A1 (de) | 2009-03-18 | 2010-09-23 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung |
UA109255C2 (ru) | 2009-04-30 | 2015-08-10 | Берінгер Інгельхайм Інтернешнл Гмбх | Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1 |
US8927539B2 (en) | 2009-06-11 | 2015-01-06 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure |
EP2448928B1 (en) | 2009-07-01 | 2014-08-13 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
EA023221B1 (ru) | 2010-02-27 | 2016-05-31 | Байер Интеллектуэль Проперти Гмбх | СВЯЗАННЫЕ БИС-АРИЛЬНЫЕ АРИЛ-ТРИАЗОЛОНЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, ИХ ПРИМЕНЕНИЕ, ЛЕКАРСТВЕННОЕ СРЕДСТВО НА ИХ ОСНОВЕ И ДВОЙНОЙ АНТАГОНИСТ V1a/V2-РЕЦЕПТОРОВ |
JP5860042B2 (ja) | 2010-06-16 | 2016-02-16 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 置換5、6及び7員複素環、そのような化合物を含有する医薬及びそれらの使用 |
WO2011161128A1 (en) | 2010-06-25 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders |
DE102010040187A1 (de) | 2010-09-02 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Substituierte N-Phenethyl-triazolonacetamide und ihre Verwendung |
DE102010040924A1 (de) | 2010-09-16 | 2012-03-22 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Phenylacet- und Phenylpropanamide und ihre Verwendung |
WO2012059416A1 (en) | 2010-11-02 | 2012-05-10 | Boehringer Ingelheim International Gmbh | Pharmaceutical combinations for the treatment of metabolic disorders |
AU2015342017B2 (en) | 2014-11-03 | 2020-02-06 | Bayer Pharma Aktiengesellschaft | Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof |
US9988367B2 (en) | 2016-05-03 | 2018-06-05 | Bayer Pharma Aktiengesellschaft | Amide-substituted pyridinyltriazole derivatives and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19627901A1 (de) * | 1996-07-11 | 1998-01-15 | Bayer Ag | Substituierte aromatische Carbonylverbindungen und ihre Derivate |
DE19921732A1 (de) * | 1998-07-24 | 2000-01-27 | Bayer Ag | Substituierte Benzoylcyclohexandione |
-
1999
- 1999-06-26 DE DE19929348A patent/DE19929348A1/de not_active Withdrawn
-
2000
- 2000-06-13 CN CN00809503A patent/CN1358176A/zh active Pending
- 2000-06-13 JP JP2001507005A patent/JP2003503396A/ja active Pending
- 2000-06-13 MX MXPA01013263A patent/MXPA01013263A/es not_active Application Discontinuation
- 2000-06-13 WO PCT/EP2000/005412 patent/WO2001000595A1/de not_active Application Discontinuation
- 2000-06-13 IL IL14666200A patent/IL146662A0/xx unknown
- 2000-06-13 EP EP00940367A patent/EP1194419A1/de not_active Withdrawn
- 2000-06-13 AU AU55325/00A patent/AU5532500A/en not_active Abandoned
- 2000-06-13 BR BR0012451-6A patent/BR0012451A/pt not_active Application Discontinuation
-
2003
- 2003-01-03 HK HK03100101.3A patent/HK1047932A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA01013263A (es) | 2002-06-21 |
DE19929348A1 (de) | 2000-12-28 |
BR0012451A (pt) | 2002-04-02 |
JP2003503396A (ja) | 2003-01-28 |
EP1194419A1 (de) | 2002-04-10 |
CN1358176A (zh) | 2002-07-10 |
WO2001000595A1 (de) | 2001-01-04 |
AU5532500A (en) | 2001-01-31 |
IL146662A0 (en) | 2002-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL146662A0 (en) | Method for producing 2-heterocyclyl methyl benzoic acid derivatives | |
IL150542A0 (en) | Method for preparing hydroxypicolinic acid derivatives | |
HK1064670A1 (en) | Pyridine-3-carboxylic acid derivatives | |
HK1039939A1 (zh) | α-取代羧酸衍生物 | |
PL345284A1 (en) | Method for producing ortho-alkylated benzoic acid derivatives | |
MXPA01013104A (es) | Metodo para producir sales de esteres alcaloides acidos sulfograsos. | |
HUP9701580A3 (en) | Process for producing benzoic acid derivatives | |
HK1047739A1 (en) | Process for phenylacetic acid derivatives | |
HRP20020427B1 (en) | Method for preparing conjugated linoleic acid | |
HK1045682A1 (en) | Method for making 2-(n-phenylamino) benzoic acids derivatives | |
HUP0203591A3 (en) | Method for producing o-chloromethyl benzoic acid chlorides | |
PL338742A1 (en) | Method of obtaining derivatives of dioxypenicillanic acid | |
PL356988A1 (en) | Method for making adipic acid | |
HU0004005D0 (en) | Method for producing (+)-trans-chrysant-henummonocarboxylic acid | |
HUP9900755A1 (en) | Process for preparing propionic acid derivatives | |
IL134912A0 (en) | Method for preparing 1-phenylpyrrazolin-3-carboxylic acid derivatives | |
AU7005800A (en) | Method for preparing a carboxylic acid | |
HUP0103116A3 (en) | Method for preparing 1-alkyl-pyrazol-5-carboxylic acid esters iii | |
IL154826A0 (en) | Method for producing ketocarboxylic acid derivatives | |
IL144619A0 (en) | Method for producing derivatives of biphenyl-2-carboxylic acid | |
AU7699800A (en) | Process for preparing benzoic acids | |
KR100641947B1 (en) | 4-jod-2[n-n-alkylaminocarbonylaminosulfonyl]benzoic acid methyl ester and derivative thereof and method for their production | |
AP9901667A0 (en) | Process for preparing trovafloxacin acid salts | |
IL149497A0 (en) | Method for producing iminodicarboxylic acids | |
HU9901729D0 (en) | Method for producing of fattic acid salt |